Board of Directors

The Board of the Children’s Cause for Cancer Advocacy is a group of committed volunteers who lend their extraordinary skills and experience to implement its mission and to work toward lightening the burden of childhood cancer for all.

  • Lynn Bayard, JD - Board ChairPaul, Weiss, Rifkind, Wharton & Garrison, LLP
  • A partner at an international law firm, Lynn has a diverse practice that encompasses a broad range of issues and areas, including intellectual property, media and entertainment related matters.

 

Wylie Chen
U.S. Soccer Foundation

As the Director of Programs and Grants for the U.S. Soccer Foundation, Wylie oversees the Foundation's programs and grantmaking efforts that focus on children in low-income and underserved communities. He previously worked at the Children's Defense Fund, establishing his career and commitment to child advocacy and improving the lives of underprivileged youth.

  •  
  • Elizabeth Goss, JD - Board Vice PresidentTurner & Goss, LLP
  • A partner at a national law firm, Elizabeth is an expert in health care, cancer policy, and cancer patient advocacy. Elizabeth brings years of legislative and regulatory experience on Capitol Hill.


  • Jennifer Niedermeyer
  • After her nephew was diagnosed with cancer, Jennifer has since been a committed and active pediatric cancer advocate. She was formerly Director of Development at a national non-profit organization dedicated to providing information and support to brain tumor patients, families and healthcare professionals.

 

David Poplack, MD
Texas Children's Cancer Center

Dr. Poplack is Director of Texas Children's Cancer Center, the largest children's cancer center in the U.S. He is Co-Editor of "Principles and Practice of Pediatric Oncology", the leading textbook in the field, now in its 6th edition. An expert on the development of new drugs for pediatric cancer, he has authored over 350 journal articles and book chapters, and has served on a number of National Cancer Institute (NCI), Food and Drug Administration and Institute of Medicine committees. He is a member of the NCI's Board of Scientific Counselors.


  • Leonard Rosen, LLB Wachtell, Lipton, Rosen & Katz
  • Leonard has a distinguished career as an attorney and founding partner of one of New York City’s most respected law firms. Since his family was touched by cancer, including childhood cancer, he has become deeply involved in cancer patient advocacy.
  •  
  • Susan Scherr, Board Secretary
  • A Certified Public Accountant and former financial analyst with HarperCollins Publishers, Susan is a stay-at-home mother of four children. Susan’s son was treated successfully for Acute Lymphoblastic Leukemia in 2001.

 

Beth Silber

Beth currently serves as a part-time parent advocate for the Mt Sinai pediatric oncology clinic. Previously, she worked as a marketing and strategic planner for Pfizer Inc. Beth’s son, a cancer survivor, finished his Acute Lymphoblastic Leukemia treatment successfully in 2007.

  •  
  • Steve Shak, MD Genomic Health, Inc.

  • Steve founded a forward-looking company to bring the benefits of genomic technology to cancer research and cancer care. As a pioneer in breast cancer patient advocacy, Steve brings the dual expertise of family experience with childhood cancer and oncology drug and diagnostic development.

 

  • Robyn L. Sterling EckerlingAon Corporation
  • Prior to entering private practice, Robyn worked for the Office of the Inspector General in the Dept. of Health and Human Services, in the areas of FDA and Medicare, where her work focused on identifying and deterring fraud, waste, and abuse. Robyn lives in Chicago, where she previously worked as an Associate in the Health Care Department at Proskauer Rose LLP. She now serves as Privacy Counsel at Aon Corporation.

 

  • John Stewart, PhD Stewart, Wright & Associates, LLC
  • John’s 3-year-old granddaughter, Sylvie Stewart, died in 2000 of a brain tumor after a valiant 18-month struggle. His 4 decades of experience on Capitol Hill and in the Executive Branch is now focused on advocacy on behalf of pediatric cancer research.

 

Zelda Tetenbaum

Zelda, a former science teacher, became a cancer advocate after her son was diagnosed with a brain tumor. In 2002, she was named to the NIH Director's Council of Public Representatives, and she most recently served as a Board Member of the North American Brain Tumor Coalition.

  •  
  • Susan L. Weiner, PhD - President and Founder of CCCA Children’s Cause for Cancer Advocacy
  • Susan, whose child was a 13-year cancer survivor, is a founding member of Children’s Cause for Cancer Advocacy. Trained as a research developmental psychologist, she worked as a childhood brain tumor and children’s disability advocate for many years.
  •  

Institutional affiliation noted for purposes of identification only.